Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP14580.RAiVJT9jk5ksh4WZz4V6gvs_TVKmDThkYNhnR0xpaS9A4130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP14580.RAiVJT9jk5ksh4WZz4V6gvs_TVKmDThkYNhnR0xpaS9A4130_provenance.
• NP22090.RA4pBAgOYy70h-smjaUA-soLEn6RJ7deM5hRbftowKE3g130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP22090.RA4pBAgOYy70h-smjaUA-soLEn6RJ7deM5hRbftowKE3g130_provenance.
• NP22121.RA87aAV2gbiO53J-cprWo2Xt4E_LGRNVoXuWpFhXKcZgw130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP22121.RA87aAV2gbiO53J-cprWo2Xt4E_LGRNVoXuWpFhXKcZgw130_provenance.
• NP10041.RA7JMxi-gmwtkCwXTKZEBoQkecNq_2jxiURHRf7PxPXkw130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10041.RA7JMxi-gmwtkCwXTKZEBoQkecNq_2jxiURHRf7PxPXkw130_provenance.
• NP8240.RABbiTaLINQFkwmGVhhwFeXDzsUcFEbxWKloEe7nmu_Ik130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8240.RABbiTaLINQFkwmGVhhwFeXDzsUcFEbxWKloEe7nmu_Ik130_provenance.
• NP10042.RASgECYQnE9FQvCdPzxZ3b_906r4KBex7IbbAnCyXYAts130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10042.RASgECYQnE9FQvCdPzxZ3b_906r4KBex7IbbAnCyXYAts130_provenance.
• assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP6467.RA8om20-OQ5ffsqrNAAa1Ke_5Mrb9Lbjd8GzZ4cLZSolE130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP6467.RA8om20-OQ5ffsqrNAAa1Ke_5Mrb9Lbjd8GzZ4cLZSolE130_provenance.
• NP13420.RA5tvAcuziCEzatR-1mupaZZj00-x-qHEa2N9WN_3B7ko130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13420.RA5tvAcuziCEzatR-1mupaZZj00-x-qHEa2N9WN_3B7ko130_provenance.
• NP21521.RA8xgs1y_PkRZTzznzu9ADGqZlGJPEPEWXEDzJuS9pN-U130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21521.RA8xgs1y_PkRZTzznzu9ADGqZlGJPEPEWXEDzJuS9pN-U130_provenance.
• NP8438.RAlS4pE1b0SvKA0c6EDAilKI5hD5E3LCh-vHs57Qa8eKU130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8438.RAlS4pE1b0SvKA0c6EDAilKI5hD5E3LCh-vHs57Qa8eKU130_provenance.
• NP8439.RAowSoHLrGk8vD-Ljdj6IHKbimmQRfuAaoGapz_LebLdw130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8439.RAowSoHLrGk8vD-Ljdj6IHKbimmQRfuAaoGapz_LebLdw130_provenance.
• assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP16088.RAb9rnvMtH0O_lCMlnr5rONBTlOc8nYGDhpJ0y6sAquOs130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16088.RAb9rnvMtH0O_lCMlnr5rONBTlOc8nYGDhpJ0y6sAquOs130_provenance.
• NP21554.RADsoCPtc0okIdqp_iwnEGef69zE3RG9aaZ_CANKImT7w130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21554.RADsoCPtc0okIdqp_iwnEGef69zE3RG9aaZ_CANKImT7w130_provenance.
• NP16089.RAjseDHq2XEJF5cnYdvgLG4P2jsvYskHnFiVYxmW8lJWE130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16089.RAjseDHq2XEJF5cnYdvgLG4P2jsvYskHnFiVYxmW8lJWE130_provenance.
• NP16090.RAvL8EWT_pt90PaEBZn2ykbaRs19freEIfnpX8HcZLjh4130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16090.RAvL8EWT_pt90PaEBZn2ykbaRs19freEIfnpX8HcZLjh4130_provenance.
• NP16091.RAsGq4I1K-jHx9ghgHCy6euNrBf-_ZhQXx0aGZWpIrd-o130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16091.RAsGq4I1K-jHx9ghgHCy6euNrBf-_ZhQXx0aGZWpIrd-o130_provenance.
• NP16086.RAExtF4HkpFeKhSjRoshvUyEwPIZ65MkZiEf_6BGbQM2A130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16086.RAExtF4HkpFeKhSjRoshvUyEwPIZ65MkZiEf_6BGbQM2A130_provenance.
• NP16087.RA2o0S_Nrf8ZCjpE3nF7U27BPzIXTcoBui2bJ-l2hTqh4130_assertion description "[Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16087.RA2o0S_Nrf8ZCjpE3nF7U27BPzIXTcoBui2bJ-l2hTqh4130_provenance.